HighPoint Advisor Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,378
Closed -$378K 741
2024
Q3
$378K Hold
5,378
0.02% 423
2024
Q2
$368K Sell
5,378
-100
-2% -$6.74K 0.02% 417
2024
Q1
$369K Sell
5,478
-3,400
-38% -$229K 0.03% 417
2023
Q4
$610K Buy
+8,878
New +$497K 0.04% 314
2022
Q2
$1.11M Buy
+17,660
New +$968K 0.12% 136
2021
Q3
$1.32M Sell
20,345
-50
-0.2% -$3.41K 0.13% 131
2021
Q2
$1.29M Sell
20,395
-1,000
-5% -$59K 0.13% 134
2021
Q1
$1.29M Sell
21,395
-4,907
-19% -$267K 0.15% 120
2020
Q4
$1.44M Buy
+26,302
New +$1.23M 0.18% 113

Other funds holding AXNX

HighPoint Advisor Group's AXNX Position: Q4 2024 in Review

HighPoint Advisor Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 5,378 shares — an estimated $378K sold.

HighPoint Advisor Group first reported a position in AXNX in Q4 2020 and held it in 9 quarters. The position peaked at $1.44M in Q4 2020. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • HighPoint Advisor Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • HighPoint Advisor Group sold 5,378 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $378K.
  • HighPoint Advisor Group first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • HighPoint Advisor Group's Axonics, Inc. Common Stock position peaked at $1.44M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on HighPoint Advisor Group's 13F filing for Q4 2024, filed 12 Feb 2025.